‪Sophie N Mathiesen‬ - ‪Google Scholar‬

Get my own profile

Cited by

	All	Since 2019
Citations	164	164
h-index	2	2
i10-index	2	2

0

80

40

202120222023202415 32 79 38

Co-authors

Wickliffe AbrahamUniversity of OtagoVerified email at otago.ac.nz
Stephanie M. HughesUniversity of OtagoVerified email at otago.ac.nz
Jasmine L. LockPhD Candidate, University of OtagoVerified email at student.otago.ac.nz
Bruce MockettResearch Fellow, University of OtagoVerified email at psy.otago.ac.nz

Sophie N Mathiesen

Sophie N Mathiesen

PhD candidate

Verified email at student.otago.ac.nz

Neuroscience Alzheimer's Disease Viral Vectors


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
CNS transduction benefits of AAV-PHP. eB over AAV9 are dependent on administration route and mouse strain SN Mathiesen, JL Lock, L Schoderboeck, WC Abraham, SM Hughes Molecular Therapy-Methods & Clinical Development 19, 447-458, 2020	108	2020
Neutrophil-vascular interactions drive myeloperoxidase accumulation in the brain in Alzheimer’s disease LCD Smyth, HC Murray, M Hill, E van Leeuwen, B Highet, NJ Magon, ... Acta Neuropathologica Communications 10 (1), 38, 2022	56	2022
Proceedings of the 251st Otago Medical School Research Society Meeting-PhD Student Speaker Awards; 9 Oct 2019 S Sethi, RA Augustine, GT Bouwer, DO Schwenke, CH Brown, ... New Zealand Medical Association, 2020		2020

The system can't perform the operation now. Try again later.

Articles 1–3